Literature DB >> 19175002

[Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy: a case report].

Masaaki Fujimura1, Kensei Chin, Nobuyuki Sekita, Syunichi Kajimoto, Syuichi Kamijima, Hiroyoshi Suzuki, Tomohiko Ichikawa, Kazuo Mikami.   

Abstract

A 69-year-old woman presented with macroscopic hematuria and severe anemia. Cystoscopy revealed flat edematous mucosa with continuous bleeding. Transurethral coagulation and a biopsy of the urinary bladder were performed. Histopathological examination of the biopsy revealed non-Hodgkin's lymphoma of the mucosa-associated lymphoid tissue (MALT) type. Results of a computed tomography scan and gallium scintigraphy suggested that it was a primary malignant lymphoma of the urinary bladder. A urinary tract infection was found and she was treated with antibiotics for 2 weeks. Because of the detection of a Helicobacter pylori (HP) infection in the gastric mucosal biopsy specimens, the patient was subsequently administered HP eradication therapy. Consequently, the lymphoma disappeared and the woman has had no tumor recurrence for the past 25 months.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19175002

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  3 in total

1.  MALT Lymphoma of the Bladder: A Case Report and Review of the Literature.

Authors:  Prashant Vempati; Miriam A Knoll; Mahfood Alqatari; James Strauchen; Adriana K Malone; Richard L Bakst
Journal:  Case Rep Hematol       Date:  2015-08-31

Review 2.  Primary bladder mucosa-associated lymphoid tissue lymphoma: A case report and literature review.

Authors:  Hewei Xu; Zhengsen Chen; Baixin Shen; Zhongqing Wei
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

3.  Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study.

Authors:  Chu-Wen Fang; Chun-Hao Chen; Chih-Hsin Muo; Shih-Chi Wu
Journal:  BMC Urol       Date:  2020-08-31       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.